Showing 151–175 of 200 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
World Health Organization. Regional Office for the Western Pacific
Grange, John M, Yates, Malcolm D, Kantor, Isabel N. de, World Health Organization. Emerging and other Communicable Diseases, Surveillance and Control
World Health Organization
World Health Organization
World Health Organization
World Health Organization
WHO Working Group on DOTS-Plus for MDR-TB. Scientific Panel, World Health Organization. Communicable Diseases Cluster
World Health Organization
World Health Organization
Choun, Kimcheng, Pe, Reaksmey, Thai, Sopheak, Lorent, Natalie, Lynen, Lutgarde, et al.
Furin, Jennifer, Gegia, Medea, Mitnick, Carole, Rich, Michael, Shin, Sonya, et al.
World Health Organization. Regional Office for South-East Asia
World Health Organization
World Health Organization. Regional Office for South-East Asia
World Health Organization. Regional Office for South-East Asia
World Health Organization
Alexander Nast, Andreas Altenburg, Matthias Augustin, Frank Bachmann, Wolf-Henning Boehncke, et al.
… major focus of this update is the chapter on screening for tuberculosis as well as therapy selection and management in latent tuberculosis. The recommendations regarding the use of interferon-gamma release assays and the indication for chest radiography have been extensively rev…
World Health Organization
…ion of vertical HIV transmission, breastfeeding support and tuberculosis preventive treatment in people living with HIV. Dolutegravir-based regimens remain highly effective for second-line therapy, while selected dual-drug regimens show comparable efficacy in specific populations…
World Health Organization
… therapy (ART), prevention of vertical HIV transmission and tuberculosis (TB) prevention among people living with HIV. It reflects new evidence and programmatic experience since the publication of the 2021 consolidated HIV guidelines and aims to support progress towards ending AI…
World Health Organization
…aches used across a range of public health areas, including tuberculosis, HIV, nutrition, reproductive health, antimicrobial resistance, road safety and pharmaceutical regulation. The case studies describe monitoring systems, indicators, databases, dashboards, surveys and countr…
World Health Organization
…laxis and treatment, and dose adjustments in the context of tuberculosis co-treatment. Programme and regulatory aspects, as well as evidence gaps and priorities for future formulation development, are also highlighted to support clinicians, programme managers and policy-makers in…
World Health Organization
… on the management of cryptococcal disease, histoplasmosis, tuberculosis, severe bacterial infections and Kaposi’s sarcoma, together with considerations related to monitoring, palliative care and drug–drug interactions. The guidelines are intended to support national HIV programm…
Silvio Henrique Barberato, Nuno Cardim, Daniela do Carmo Rassi, Anna Baritussio, Adenalva Lima de Souza Beck, et al.
…ctions today, such as dengue, malaria, schistosomiasis, and tuberculosis, but excludes Chagas disease and rheumatic fever, which have been extensively covered in other documents. When used effectively, cardiovascular imaging can potentially aid in early diagnosis, prevention of c…
Ying-Ying Leung, Paul Bird, Muhammad Haroon, Mitsumasa Kishimoto, Kichul Shin, et al.
…l disease, and screening for chronic hepatitis B and latent tuberculosis were reviewed. The working group discussed and reached consensus on eight management principles and 16 recommendation statements for managing PsA. Endorsement from an external voting panel (n = …
A Bamford, A Turkova, H Lyall, C Foster, N Klein, et al.
… expanded guidance on management of coinfections (including tuberculosis, hepatitis B and hepatitis C) and additional emphasis on the needs of adolescents as they approach transition to adult services. There is a new section on the current ART 'pipeline' of drug development, a co…